Table 2.
Parameters | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
|
|
|||||
HR | 95% Cl | p value | HR | 95% Cl | p value | |
Age | ||||||
<70* | ||||||
≥70 | 1.648 | 1.047–2.594 | 0.028 | 1.630 | 1.092–2.608 | 0.042 |
Gender | ||||||
Female | ||||||
Male | 1.322 | 0.832–2.026 | 0,736 | |||
Lymph node invasion | ||||||
Negative* | ||||||
Positive | 3.940 | 2.623–5.919 | <0.001 | 1.517 | 1.097–2.370 | 0.030 |
Pathological stage | ||||||
T2≤* | ||||||
T2> | 7.114 | 4.716–10.730 | <0.001 | 5.463 | 3.469–8.606 | <0.001 |
Histologic type | ||||||
Urothelial carcinoma | ||||||
Non-urothelial carcinoma | 2.116 | 1.428–3.136 | <0.001 | 1.533 | 1.020–2.305 | 0.040 |
Surgical margin | ||||||
Negative* | ||||||
Positive | 1.852 | 1.062–3.231 | 0,026 | |||
Grade | ||||||
Low* | ||||||
High | 4.741 | 2.864–7.848 | <0.001 | 3.337 | 1.993–5.587 | <0.001 |
Lymphovascular invasion | ||||||
Negative* | ||||||
Positive | 2.690 | 1.840–3.934 | <0.001 | |||
Carcinoma in-situ | ||||||
Positive* | ||||||
Negative | 1.164 | 0.920–1.487 | 0,125 | |||
Preoperative hydronephrosis | ||||||
Negative* | ||||||
Positive | 2.359 | 1.637–3.398 | <0.001 | |||
Leukocyte | ||||||
≤11 000* | ||||||
>11 000 | 2.086 | 1.314–3.310 | 0.002 | 1.773 | 1.096–2.687 | 0.020 |
Neutrophil | ||||||
<7700* | ||||||
≥7700 | 1.528 | 1.023–2.283 | 0.035 | |||
Lymphocyte >1500 | ||||||
Lymphocyte ≤1500 | 1.435 | 0.816–2.532 | 0.691 | |||
NLR | ||||||
<2.5* | ||||||
≥2.5 | 1.798 | 1.260–2.567 | 0.001 | 1.965 | 1.042–3.586 | 0.022 |
CI: Confidence interval; HR: hazard ratio;
Reference category; NLR: neutrophil-to-lymphocyte ratio.